ESC Professional Premium Access

Optimising PCI: imaging, pharmacology and more

Event: ESC Congress 2022
Topic: Percutaneous Coronary Intervention (PCI)
Session type: Abstract Sessions
Date: 29 August 2022
Time: 12:45 - 13:25

Congress Session

4 presentations in this session

Effect of aspirin discontinuation according to individualised patient bleeding and ischemic risks after PCI: a TWILIGHT trial sub-analysis.

Speaker: Doctor G. Mendieta Badimon (Madrid, ES)

Heparin pre-treatment in patients with ST elevation myocardial infarction: a cohort study investigating the effects on coronary artery occlusion, mortality, and bleeding

Speaker: Mr O. Emilsson (Lund, SE)

Intravascular ultrasound-guided optimization for chronic total occlusion-percutaneous coronary intervention with multiple drug-eluting stents

Speaker: Doctor S. Seo (Seoul, KR)

Shockwave intravascular lithotripsy (IVL) for calcified coronary lesions; a real world multicentre European study with long term follow up

Speaker: Doctor W. Raja (Birmingham, GB)

4 speakers from this session

Doctor Guiomar Mendieta Badimon

National Centre for Cardiovascular Research (CNIC), Madrid (Spain)
1 follower

Mr Oskar Love Emilsson

Lund University, Lund (Sweden)
0 follower

Doctor Sukmin Seo

Eunpyeong St. Marys Hospital, Seoul (Korea (Republic of))
0 follower

Doctor Waseem Raja

Birmingham Heartlands Hospital, Birmingham (United Kingdom of Great Britain & Northern Ireland)
0 follower

This platform is supported by

logo Novo Nordisk